XML 128 R47.htm IDEA: XBRL DOCUMENT v3.20.1
Quarterly Financial Information Restatement of Statement of Cash Flows (Tables)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Jun. 30, 2019
Jun. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Condensed Cash Flow Statement [Table Text Block] ta
 
Six Months Ended June 30, 2019
 
As Reported
 
Restatement Adjustments
 
Other Adjustments
 
As Restated
Cash flows from operating activities:
 
 
 
 
 
 
 
Net income (loss)
$
456

 
$
(47
)
 
$
—

 
$
409

Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
 
 
 
 
 
 


Increase (decrease) in other liabilities
30

 
47

 
—

 
77

Net cash provided by (used for) operating activities
1,227

 
—

 
—

 
1,227

Net increase (decrease) in cash, cash equivalents, and restricted cash
16

 
—

 
—

 
16

Cash, cash equivalents, and restricted cash at beginning of period
413

 
—

 
—

 
413

Cash, cash equivalents, and restricted cash at end of period
$
429

 
$
—

 
$
—

 
$
429


 t
 
Nine Months Ended September 30, 2019
 
As Reported
 
Restatement Adjustments
 
Other Adjustments
 
As Restated
Cash flows from operating activities:
 
 
 
 
 
 
 
Net income (loss)
$
729

 
$
(77
)
 
$
—

 
$
652

Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
 
 
 
 
 
 
 
Depreciation, amortization and accretion
1,176

 
—

 
(1
)
 
1,175

Increase (decrease) in other liabilities
102

 
77

 
—

 
179

Net cash provided by (used for) operating activities
1,891

 
—

 
(1
)
 
1,890

Cash flows from investing activities:
 
 
 
 
 
 
 
Capital expenditures
(1,538
)
 
—

 
1

 
(1,537
)
Net cash provided by (used for) investing activities
(1,550
)
 
—

 
1

 
(1,549
)
Net increase (decrease) in cash, cash equivalents, and restricted cash
(88
)
 
—

 
—

 
(88
)
Cash, cash equivalents, and restricted cash at beginning of period
413

 
—

 
—

 
413

Cash, cash equivalents, and restricted cash at end of period
$
325

 
$
—

 
$
—

 
$
325


 Flows
 
September 30, 2019
 
June 30, 2019
 
March 31, 2019
 
Nine Months Ended
 
Six Months Ended
 
Three Months Ended
 
(As Restated)
Cash flows from operating activities:
 
 
 
 
 
Net income (loss)
$
652

 
$
409

 
$
193

Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
 
 
 
 
 
Depreciation, amortization and accretion
1,175

 
787

 
394

(Gains) losses on retirement of long-term obligations
2

 
2

 
1

Amortization of deferred financing costs and other non-cash interest
1

 
1

 
1

Stock-based compensation expense
91

 
62

 
29

Asset write-down charges
13

 
12

 
6

Deferred income tax (benefit) provision
2

 
1

 
1

Other non-cash adjustments, net
4

 
3

 
2

Changes in assets and liabilities, excluding the effects of acquisitions:
 
 
 
 
 
Increase (decrease) in accrued interest
(38
)
 
18

 
(41
)
Increase (decrease) in accounts payable
37

 
6

 
(5
)
Increase (decrease) in other liabilities
179

 
77

 
(7
)
Decrease (increase) in receivables
(166
)
 
(89
)
 
(43
)
Decrease (increase) in other assets
(62
)
 
(62
)
 
(19
)
Net cash provided by (used for) operating activities
1,890

 
1,227

 
512

Cash flows from investing activities:
 
 
 
 
 
Capital expenditures
(1,537
)
 
(998
)
 
(480
)
Payments for acquisitions, net of cash acquired
(15
)
 
(13
)
 
(10
)
Other investing activities, net
3

 
1

 
1

Net cash provided by (used for) investing activities
(1,549
)
 
(1,010
)
 
(489
)
Cash flows from financing activities:
 
 
 
 
 
Proceeds from issuance of long-term debt
1,895

 
995

 
996

Principal payments on debt and other long-term obligations
(59
)
 
(36
)
 
(25
)
Purchases and redemptions of long-term debt
(12
)
 
(12
)
 
(12
)
Borrowings under revolving credit facility
1,585

 
1,195

 
710

Payments under revolving credit facility
(2,270
)
 
(1,785
)
 
(1,140
)
Net issuances (repayments) under commercial paper program
—

 
500

 
—

Payments for financing costs
(24
)
 
(14
)
 
(10
)
Purchases of common stock
(44
)
 
(43
)
 
(42
)
Dividends/distributions paid on common stock
(1,415
)
 
(944
)
 
(477
)
Dividends/distributions paid on preferred stock
(85
)
 
(57
)
 
(28
)
Net cash provided by (used for) financing activities
(429
)
 
(201
)
 
(28
)
Net increase (decrease) in cash, cash equivalents, and restricted cash
(88
)
 
16

 
(5
)
Effect of exchange rate changes on cash
—

 
—

 
—

Cash, cash equivalents, and restricted cash at beginning of period
413

 
413

 
413

Cash, cash equivalents, and restricted cash at end of period
325

 
429

 
408

 
September 30, 2018
 
June 30, 2018
 
March 31, 2018
 
Nine Months Ended
 
Six Months Ended
 
Three Months Ended
 
(As Restated)
Cash flows from operating activities:
 
 
 
 
 
Net income (loss)
$
421

 
$
270

 
$
100

Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
 
 
 
 
 
Depreciation, amortization and accretion
1,138

 
753

 
374

(Gains) losses on retirement of long-term obligations
106

 
74

 
71

Amortization of deferred financing costs and other non-cash interest
5

 
4

 
2

Stock-based compensation expense
79

 
47

 
23

Asset write-down charges
18

 
9

 
3

Deferred income tax (benefit) provision
2

 
1

 
1

Other non-cash adjustments, net
2

 
1

 
2

Changes in assets and liabilities, excluding the effects of acquisitions:
 
 
 
 
 
Increase (decrease) in accrued interest
(31
)
 
22

 
(28
)
Increase (decrease) in accounts payable
31

 
3

 
(5
)
Increase (decrease) in other liabilities
179

 
76

 
(43
)
Decrease (increase) in receivables
(74
)
 
(59
)
 
(5
)
Decrease (increase) in other assets
(103
)
 
(91
)
 
(43
)
Net cash provided by (used for) operating activities
1,773

 
1,110

 
452

Cash flows from investing activities:
 
 
 
 
 
Capital expenditures
(1,239
)
 
(762
)
 
(370
)
Payments for acquisitions, net of cash acquired
(26
)
 
(18
)
 
(14
)
Other investing activities, net
(14
)
 
3

 
—

Net cash provided by (used for) investing activities
(1,279
)
 
(777
)
 
(384
)
Cash flows from financing activities:
 
 
 
 
 
Proceeds from issuance of long-term debt
2,743

 
1,743

 
1,743

Principal payments on debt and other long-term obligations
(76
)
 
(47
)
 
(32
)
Purchases and redemptions of long-term debt
(2,346
)
 
(1,318
)
 
(1,318
)
Borrowings under revolving credit facility
1,290

 
485

 
170

Payments under revolving credit facility
(1,465
)
 
(1,150
)
 
(1,050
)
Payments for financing costs
(33
)
 
(20
)
 
(15
)
Net proceeds from issuance of common stock
841

 
841

 
843

Purchases of common stock
(34
)
 
(34
)
 
(33
)
Dividends/distributions paid on common stock
(1,315
)
 
(879
)
 
(443
)
Dividends/distributions paid on preferred stock
(85
)
 
(57
)
 
(28
)
Net cash provided by (used for) financing activities
(480
)
 
(436
)
 
(163
)
Net increase (decrease) in cash, cash equivalents, and restricted cash
14

 
(103
)
 
(95
)
Effect of exchange rate changes on cash
(1
)
 
(1
)
 
—

Cash, cash equivalents, and restricted cash at beginning of period
440

 
440

 
440

Cash, cash equivalents, and restricted cash at end of period
453

 
336

 
345

The following tables illustrate the Historical Adjustments, where applicable, on the Company’s condensed consolidated statement of cash flows for each period. Only line items impacted by the Historical Adjustments are presented, and as such, components will not sum to 		s rately.

Consolidated Statement of Cas
Consolidated Statement of Cash Flows
 
Year Ended December 31, 2018
 
As Reported
 
Restatement Adjustments
 
Other Adjustments
 
As Restated
Cash flows from operating activities:
 
 
 
 
 
 
 
Net income (loss)
$
671

 
$
(48
)
 
$
(1
)
 
$
622

Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
 
 
 
 
 
 


Depreciation, amortization and accretion
1,528

 
—

 
(1
)
 
1,527

Increase (decrease) in other liabilities
223

 
48

 
—

 
271

Net cash provided by (used for) operating activities
2,502

 
—

 
(2
)
 
2,500

Cash flows from investing activities:
 
 
 
 
 
 
 
Capital expenditures
(1,741
)
 
—

 
2

 
(1,739
)
Net cash provided by (used for) investing activities
(1,795
)
 
—

 
2

 
(1,793
)
Net increase (decrease) in cash, cash equivalents, and restricted cash
(26
)
 
—

 
—

 
(26
)
Cash, cash equivalents, and restricted cash at beginning of period
440

 
—

 
—

 
440

Cash, cash equivalents, and restricted cash at end of period
$
413

 
$
—

 
$
—

 
$
413
 
Year Ended December 31, 2017
 
As Reported
 
Restatement Adjustments
 
Other Adjustments
 
As Restated
Cash flows from operating activities:
 
 
 
 
 
 
 
Net income (loss)
$
445

 
$
(59
)
 
$
(20
)
 
$
366

Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:

 
 
 
 
 

Depreciation, amortization and accretion
1,242

 
—

 
(1
)
 
1,241

Increase (decrease) in other liabilities
175

 
59

 
—

 
234

Decrease (increase) in receivables
61

 
—

 
10

 
71

Net cash provided by (used for) operating activities
2,043

 
—

 
(11
)
 
2,032

Cash flows from investing activities:
 
 
 
 
 
 

Capital expenditures
(1,228
)
 
—

 
11

 
(1,217
)
Net cash provided by (used for) investing activities
(10,493
)
 
—

 
11

 
(10,482
)
Net increase (decrease) in cash, cash equivalents, and restricted cash
(258
)
 
—

 
—

 
(258
)
Cash, cash equivalents, and restricted cash at beginning of period
697

 
—

 
—

 
697

Cash, cash equivalents, and restricted cash at end of period
$
440

 
$
—

 
$
—

 
$
440